ARCHIVES

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

This article is from The Cancer Letter archive.

Vol. 12 No. 41 | October 24, 1986

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

January 25, 2013

Obama Signs Spending Bill for FY09

March 13, 2009

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

September 9, 1994

Lifestyle Changes Common After Cancer Diagnosis

August 26, 2005

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002